HUP0004071A3 - Pharmaceutical compositions comprising prostaglandin derivatives - Google Patents

Pharmaceutical compositions comprising prostaglandin derivatives

Info

Publication number: HUP0004071A3
Authority: HU; Hungary
Prior art keywords: pharmaceutical compositions; prostaglandin derivatives; prostaglandin; derivatives; pharmaceutical
Prior art date: 1997-06-19

Application number

HU0004071A

Other languages

English (en)

Original Assignee

Nicox Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-19

Filing date

1998-06-17

Publication date

2002-12-28

1998-06-17 Application filed by Nicox Sa filed Critical Nicox Sa

2001-04-28 Publication of HUP0004071A2 publication Critical patent/HUP0004071A2/hu

2002-12-28 Publication of HUP0004071A3 publication Critical patent/HUP0004071A3/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

HU0004071A 1997-06-19 1998-06-17 Pharmaceutical compositions comprising prostaglandin derivatives HUP0004071A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT97MI001440A IT1292377B1 (it)	1997-06-19	1997-06-19	Composizioni farmaceutiche a base di prostaglandine
PCT/EP1998/003645 WO1998058910A1 (en)	1997-06-19	1998-06-17	Prostaglandin pharmaceutical compositions

Publications (2)

Publication Number	Publication Date
HUP0004071A2 HUP0004071A2 (hu)	2001-04-28
HUP0004071A3 true HUP0004071A3 (en)	2002-12-28

Family

ID=11377397

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0004071A HUP0004071A3 (en)	1997-06-19	1998-06-17	Pharmaceutical compositions comprising prostaglandin derivatives

Country Status (19)

Country	Link
US (1)	US6211233B1 (hu)
EP (1)	EP0989972B1 (hu)
JP (1)	JP4394170B2 (hu)
KR (1)	KR20010013625A (hu)
CN (1)	CN1260778A (hu)
AT (1)	ATE225771T1 (hu)
AU (1)	AU740683B2 (hu)
BR (1)	BR9810163B1 (hu)
CA (1)	CA2292836C (hu)
DE (1)	DE69808619T2 (hu)
DK (1)	DK0989972T3 (hu)
ES (1)	ES2185188T3 (hu)
HU (1)	HUP0004071A3 (hu)
IL (1)	IL132690A (hu)
IT (1)	IT1292377B1 (hu)
PT (1)	PT989972E (hu)
RU (1)	RU2000100807A (hu)
SI (1)	SI0989972T1 (hu)
WO (1)	WO1998058910A1 (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9801398D0 (en)	1998-01-22	1998-03-18	Anggard Erik E	Chemical compounds
WO2000051978A1 (en) *	1999-03-01	2000-09-08	Nitromed, Inc.	Nitrosated and nitrosylated prostaglandins, compositions and metods of use
IT1311923B1 (it)	1999-04-13	2002-03-20	Nicox Sa	Composti farmaceutici.
IT1319201B1 (it) *	2000-10-12	2003-09-26	Nicox Sa	Farmaci per il diabete.
AU2002243795A1 (en) *	2001-01-30	2002-08-12	Pharmaceutical Research Corporation	Use of prostaglandin analogs for treatment of cardiac conditions
GB0111872D0 (en) *	2001-05-15	2001-07-04	Northwick Park Inst For Medica	Therapeutic agents and methods
US20080026984A1 (en) *	2002-02-04	2008-01-31	Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda	Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP1476168A2 (en) *	2002-02-04	2004-11-17	ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda.	Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
US7968605B2 (en) *	2002-02-04	2011-06-28	ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda.	Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
AU2003278565A1 (en) *	2002-10-25	2004-05-13	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
GB2395432B (en) *	2002-11-20	2005-09-14	Northwick Park Inst For Medica	Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
PL1704141T3 (pl)	2004-01-05	2016-08-31	Nicox Sa	Nitrooksypochodne prostaglandyn
EP1899295A2 (en) *	2005-06-29	2008-03-19	Pfizer, Inc.	Prostaglandin derivatives
CA2613010A1 (en) *	2005-06-29	2007-01-04	Pfizer Inc.	Fluoroprostaglandins nitroderivatives
WO2007073226A1 (en) *	2005-12-20	2007-06-28	Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda	Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en)	2006-01-24	2006-03-01	Hemocorm Ltd	Therapeutic delivery of carbon monoxide
US8067414B2 (en) *	2006-03-29	2011-11-29	Nicox S.A.	Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
US8041859B2 (en) *	2007-11-05	2011-10-18	Honywell International Inc.	Apparatus and method for connectivity in networks capable of non-disruptively disconnecting peripheral devices
US9163044B2 (en)	2011-04-19	2015-10-20	Alfama, Inc.	Carbon monoxide releasing molecules and uses thereof
EP2734235B1 (en)	2011-07-21	2017-03-22	Alfama, Inc.	Ruthenium carbon monoxide releasing molecules and uses thereof
US9844599B2 (en)	2013-01-21	2017-12-19	Apparao Satyam	Nitric oxide releasing produgs of therapeutic agents
CN119350280A (zh) *	2021-11-18	2025-01-24	广州楷石医药有限公司	一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
CN116178233A (zh) *	2023-02-27	2023-05-30	广州楷石生物科技有限公司	伊洛前列素一氧化氮供体药物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3371199D1 (en) *	1982-08-24	1987-06-04	Teijin Ltd	Novel 6-nitroprostaglandin derivatives, process for production thereof, and use thereof
SE463851B (sv)	1988-09-02	1991-02-04	Amsu Ltd	Komposition foer behandling av erektil dysfunktion via uretra
IT1243367B (it)	1990-07-26	1994-06-10	Italfarmaco Spa	Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
US5352708A (en)	1992-09-21	1994-10-04	Allergan, Inc.	Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5328933A (en)	1992-10-28	1994-07-12	Allergan, Inc.	Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
AU702662B2 (en) *	1994-05-10	1999-02-25	Nicox S.A.	Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
US5625083A (en) *	1995-06-02	1997-04-29	Bezuglov; Vladimir V.	Dinitroglycerol esters of unsaturated fatty acids and prostaglandins

1997
- 1997-06-19 IT IT97MI001440A patent/IT1292377B1/it active IP Right Grant
1998
- 1998-06-17 RU RU2000100807/04A patent/RU2000100807A/ru not_active Application Discontinuation
- 1998-06-17 SI SI9830313T patent/SI0989972T1/xx unknown
- 1998-06-17 EP EP98934967A patent/EP0989972B1/en not_active Expired - Lifetime
- 1998-06-17 IL IL13269098A patent/IL132690A/en not_active IP Right Cessation
- 1998-06-17 WO PCT/EP1998/003645 patent/WO1998058910A1/en not_active Application Discontinuation
- 1998-06-17 JP JP50373899A patent/JP4394170B2/ja not_active Expired - Lifetime
- 1998-06-17 CA CA002292836A patent/CA2292836C/en not_active Expired - Lifetime
- 1998-06-17 ES ES98934967T patent/ES2185188T3/es not_active Expired - Lifetime
- 1998-06-17 BR BRPI9810163-3A patent/BR9810163B1/pt not_active IP Right Cessation
- 1998-06-17 AT AT98934967T patent/ATE225771T1/de active
- 1998-06-17 HU HU0004071A patent/HUP0004071A3/hu unknown
- 1998-06-17 PT PT98934967T patent/PT989972E/pt unknown
- 1998-06-17 KR KR19997011635A patent/KR20010013625A/ko not_active Application Discontinuation
- 1998-06-17 CN CN98806194A patent/CN1260778A/zh active Pending
- 1998-06-17 DE DE69808619T patent/DE69808619T2/de not_active Expired - Lifetime
- 1998-06-17 AU AU84386/98A patent/AU740683B2/en not_active Expired
- 1998-06-17 DK DK98934967T patent/DK0989972T3/da active
- 1998-06-17 US US09/423,286 patent/US6211233B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU740683B2 (en)	2001-11-08
EP0989972B1 (en)	2002-10-09
EP0989972A1 (en)	2000-04-05
IT1292377B1 (it)	1999-02-08
JP4394170B2 (ja)	2010-01-06
BR9810163A (pt)	2000-08-08
WO1998058910A1 (en)	1998-12-30
SI0989972T1 (en)	2003-04-30
KR20010013625A (ko)	2001-02-26
CA2292836C (en)	2010-03-02
ATE225771T1 (de)	2002-10-15
DK0989972T3 (da)	2003-02-10
IL132690A (en)	2004-06-01
CN1260778A (zh)	2000-07-19
DE69808619D1 (de)	2002-11-14
CA2292836A1 (en)	1998-12-30
HUP0004071A2 (hu)	2001-04-28
JP2002506440A (ja)	2002-02-26
US6211233B1 (en)	2001-04-03
ITMI971440A1 (it)	1998-12-19
DE69808619T2 (de)	2003-06-12
ES2185188T3 (es)	2003-04-16
BR9810163B1 (pt)	2009-01-13
AU8438698A (en)	1999-01-04
IL132690A0 (en)	2001-03-19
PT989972E (pt)	2003-02-28
RU2000100807A (ru)	2002-02-27
ITMI971440A0 (hu)	1997-06-19

Publication	Publication Date	Title
NZ304982A (en)	1999-03-29	Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions
HUP0004071A3 (en)	2002-12-28	Pharmaceutical compositions comprising prostaglandin derivatives
IL134961A0 (en)	2001-05-20	Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
GB9727053D0 (en)	1998-02-18	Pharmaceutical compositions
EG24118A (en)	2008-07-06	Pharmaceutical compositions
CY2569B1 (en)	2008-07-02	Pharmaceutical compositions
AU8107998A (en)	1998-12-11	Pharmaceutical compositions
GB9616672D0 (en)	1996-09-25	Pharmaceutical compositions
GB9610359D0 (en)	1996-07-24	Pharmaceutical compositions
IL131995A0 (en)	2001-03-19	Gastric-retained pharmaceutical compositions
GB9723985D0 (en)	1998-01-14	Pharmaceutical compositions
ZA9710919B (en)	1999-06-04	Pharmaceutical compositions containing N-sulphony-lindole derivatives
GB9726735D0 (en)	1998-02-18	Pharmaceutical compositions
ZA979726B (en)	1999-04-29	Pharmaceutical compositions
GB9606429D0 (en)	1996-06-05	Pharmaceutical compositions
HU9700632D0 (en)	1997-05-28	Pharmaceutical compositions
GB9613457D0 (en)	1996-08-28	Pharmaceutical compositions
GB9802472D0 (en)	1998-04-01	Pharmaceutical compositions
HUP0003159A3 (en)	2001-07-30	The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
GB9618376D0 (en)	1996-10-16	Pharmaceutical compositions
GB9610136D0 (en)	1996-07-24	Pharmaceutical compositions
GB9921495D0 (en)	1999-11-17	Pharmaceutical compositions
GB9714328D0 (en)	1997-09-10	Pharmaceutical compositions
GB9710505D0 (en)	1997-07-16	Pharmaceutical compositions
GB9725563D0 (en)	1998-02-04	Pharmaceutical compositions